Agenus (AGEN) Asset Utilization Ratio (2011 - 2026)
Agenus' (AGEN) quarterly Asset Utilization Ratio came in at 0.6 in Q1 2026, up 28.44% year-on-year from 0.47 in Q1 2025, and up 20.92% quarter-over-quarter from 0.5 in Q4 2025.
Agenus (AGEN) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Agenus' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.6 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 28.44% year-over-year to 0.6 in Q1 2026; TTM through Mar 2026 was 0.6, a 28.44% increase from a year earlier, with the FY2025 full-year figure at 0.5, up 31.6% from the prior year.
- Asset Utilization Ratio rose to 0.6 in Q1 2026 per AGEN's latest filing, from 0.5 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.71 in Q2 2022 and bottomed at 0.05 in Q1 2023.
- The 5-year median for Asset Utilization Ratio is 0.5 (2025), against an average of 0.42.
- Across the five-year window, Asset Utilization Ratio slumped 92.11% in 2023 and soared 950.37% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.06 in 2022, then surged by 701.61% to 0.48 in 2023, then slipped by 7.52% to 0.45 in 2024, then gained by 11.35% to 0.5 in 2025, then rose by 20.92% to 0.6 in 2026.
- Per Business Quant, the three latest AGEN Asset Utilization Ratio figures stand at 0.6 (Q1 2026), 0.5 (Q4 2025), and 0.51 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.53 |
| Mar 31, 2025 | 0.47 |
| Dec 31, 2024 | 0.45 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | 0.57 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.71 |
| Mar 31, 2022 | 0.68 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | 0.97 |
| Jun 30, 2021 | 0.32 |